Literature DB >> 19629564

Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients.

Roselia Maria Spanevello1, Cinthia Melazzo Mazzanti, Margarete Bagatini, Maisa Correa, Roberta Schmatz, Naiara Stefanello, Gustavo Thomé, Vera Maria Morsch, Lara Becker, Luziane Bellé, Liliane de Oliveira, Maria Rosa Chitolina Schetinger.   

Abstract

Multiple sclerosis (MS) is the most common chronic disabling neurological disease in young adults. Alterations in platelet function have been observed in MS; however, the mechanism and the relevance of this blood cell disorder with regard to MS pathogenesis are not yet understood. The aim of this study was to evaluate activities of ectonucleoside thiphosphate diphosphohydrolase (NTPDase, CD39), ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP), 5'-nucleotidase and adenosine deaminase (ADA) in platelets from patients with the relapsing-remitting form of MS (RRMS), as well as to analyze platelet aggregation and expression of NTPDase. The results obtained show that NTPDase, 5'-nucleotidase, E-NPP and ADA activities were decreased in platelets of RRMS patients when compared with the control group (p < 0.05). In addition, NTPDase expression in platelets was also decreased in these patients (p < 0.05); however, no differences were observed in platelet aggregation between RRMS patients and the control group. Our results suggest that the alterations in NTPDase, E-NPP, 5'-nucleotidase and ADA may have contributed to the alterations in platelet function in MS by altering the levels of nucleotides and nucleosides in the circulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629564     DOI: 10.1007/s00415-009-5258-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

Review 1.  NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.

Authors:  Maria Rosa C Schetinger; Vera Maria Morsch; Carla Denise Bonan; Angela T S Wyse
Journal:  Biofactors       Date:  2007       Impact factor: 6.113

2.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

3.  Platelet stickiness in multiple sclerosis.

Authors:  J H Millar; J D Merrett; A M Dalby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-06       Impact factor: 10.154

Review 4.  Cell surface adenosine deaminase: much more than an ectoenzyme.

Authors:  R Franco; V Casadó; F Ciruela; C Saura; J Mallol; E I Canela; C Lluis
Journal:  Prog Neurobiol       Date:  1997-07       Impact factor: 11.685

5.  Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon-beta.

Authors:  Roselia M Spanevello; Cinthia M Mazzanti; Paula A Maldonado; Rafael Zanin; André Morsch; Laura Hannel; Alexandre Mazzanti; Rafael Festugatto; Dominguita Graça; Roberta Schmatz; Vânia Lúcia Loro; Maria Rosa C Schetinger; Vera M Morsch
Journal:  Life Sci       Date:  2006-12-08       Impact factor: 5.037

6.  Cerebral venous thrombosis in four patients with multiple sclerosis.

Authors:  N Vandenberghe; M Debouverie; R Anxionnat; P Clavelou; S Bouly; M Weber
Journal:  Eur J Neurol       Date:  2003-01       Impact factor: 6.089

Review 7.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

8.  Coagulation status and biochemical and inflammatory markers in multiple sclerosis.

Authors:  Fehime B Aksungar; Aynur E Topkaya; Zeynep Yildiz; Sevki Sahin; Ulku Turk
Journal:  J Clin Neurosci       Date:  2008-02-06       Impact factor: 1.961

9.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  11 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  NPP4 is a procoagulant enzyme on the surface of vascular endothelium.

Authors:  Ronald A Albright; William C Chang; Donna Robert; Deborah L Ornstein; Wenxiang Cao; Lynn Liu; Meredith E Redick; J Isaac Young; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Blood       Date:  2012-09-20       Impact factor: 22.113

3.  Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats.

Authors:  Fátima Husein Abdalla; Andréia Machado Cardoso; Luciane Belmonte Pereira; Roberta Schmatz; Jamile Fabbrin Gonçalves; Naiara Stefanello; Amanda Maino Fiorenza; Jessié Martins Gutierres; Jonas Daci da Silva Serres; Daniela Zanini; Victor Camera Pimentel; Juliano Marchi Vieira; Maria Rosa Chitolina Schetinger; Vera Maria Morsch; Cinthia Melazzo Mazzanti
Journal:  Mol Cell Biochem       Date:  2013-09       Impact factor: 3.396

4.  Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease.

Authors:  Viviane do Carmo Gonçalves Souza; Karine B Schlemmer; Cristiano B Noal; Jeandre A S Jaques; Margarete D Bagatini; Victor C Pimentel; Luiz Felipe D Carli; Cláudio A M Leal; Juliana Fleck; Maria B Moretto; Maria R C Schetinger; Daniela B R Leal
Journal:  Purinergic Signal       Date:  2012-07-01       Impact factor: 3.765

5.  Exercise training prevents ecto-nucleotidases alterations in platelets of hypertensive rats.

Authors:  Andréia Machado Cardoso; Margarete Dulce Bagatini; Caroline Curry Martins; Fátima Hussein Abdalla; Daniela Zanini; Roberta Schmatz; Jessié Gutierres; Victor Camera Pimentel; Gustavo Thomé; Claudio Alberto Martins Leal; Juliano Marchi Vieira; Naiara Stefanello; Fernando da Silva Fiorin; Jucimara Baldissareli; Luiz Fernando Freire Royes; Adriane Bello Klein; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2012-08-23       Impact factor: 3.396

6.  Alterations in the extracellular catabolism of nucleotides and platelet aggregation induced by high-fat diet in rats: effects of α-tocopherol.

Authors:  Jessié M Gutierres; Fabiano B Carvalho; Maria Rosa C Schetinger; Marília V Rodrigues; Juliano M Vieira; Paula Maldonado; Maria do Carmo S Araújo; Roberta Schmatz; Naiara Stefanello; Jeandre A S Jaques; Marcio Costa; Vera Morsch; Cinthia M Mazzanti; Victor Pimentel; Sonia Terezinha A Lopes; Roselia M Spanevello
Journal:  J Physiol Biochem       Date:  2014-03-13       Impact factor: 4.158

7.  Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.

Authors:  Marek Cieślak; Filip Kukulski; Michał Komoszyński
Journal:  Purinergic Signal       Date:  2011-07-27       Impact factor: 3.765

8.  Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.

Authors:  Marcio S Medeiros; Arthur Schumacher-Schuh; Andreia Machado Cardoso; Guilherme Vargas Bochi; Jucimara Baldissarelli; Aline Kegler; Daniel Santana; Carolina Maria Martins Behle Soares Chaves; Maria Rosa Chitolina Schetinger; Rafael Noal Moresco; Carlos R M Rieder; Michele Rechia Fighera
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  MODULATION OF KEY BIOCHEMICAL MARKERS RELEVANT TO STROKE BY ANTIARIS AFRICANA LEAF EXTRACT FOLLOWING CEREBRAL ISCHEMIA/REPERFUSION INJURY.

Authors:  Omotayo B Ilesanmi; Afolabi C Akinmoladun; Olanrewaju Sam Olayeriju; Ibrahim Olabayode Saliu; M Tolulope Olaleye; Afolabi A Akindahunsi
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

Review 10.  The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.

Authors:  Margarete Dulce Bagatini; Alessandra Antunes Dos Santos; Andréia Machado Cardoso; Aline Mânica; Cristina Ruedell Reschke; Fabiano Barbosa Carvalho
Journal:  J Immunol Res       Date:  2018-08-12       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.